Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies [Phase 1]
Phase 1 study of COM902, a TIGIT inhibitor, in patients with advanced malignancies is ongoing and currently not recruiting.
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial
This clinical trial prospectively investigates whether counts of circulating progenitor cells (CPCs) measured by flow cytometry have prognos…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating CAR-GPRC5D cell therapy in patients with relapsed/refractory multiple myelom…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT) [Phase 2]
This clinical trial update indicates that a Phase 2 study of iberdomide in people with multiple myeloma who have previously undergone autolo…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis [Phase 2]
This phase 2 study is evaluating the CAR-T therapy HBI0101 (NXC-201) in patients with multiple myeloma (refractory or relapsed) and light-ch…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Iberdomide Maintenance Therapy in Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating Iberdomide as maintenance therapy in adults with multiple myeloma; trial is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma [Phase 2]
Phase 2 clinical trial evaluating Mecapegfilgrastim with chemotherapy for peripheral blood stem cell mobilization in adults with multiple my…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy [Phase 1]
This document provides a status update for a Phase 1 clinical trial evaluating the SVN53-67/M57-KLH peptide vaccine in newly diagnosed multi…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT [Phase 2]
This Phase 2 trial is comparing autologous stem cell transplant followed by anti-BCMA CAR-T therapy versus autologous transplant alone in pa…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: MMRF Molecular Profiling Protocol
MMRF updates its molecular profiling protocol for multiple myeloma and plasma malignancies. The trial remains active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]
Clinical trial update for a Phase Ib study of SAR650984 in combination with carfilzomib for relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies [Phase 1, Phase 2]
IDP-121 is being studied in a Phase 1/2 trial for relapsed/refractory hematologic malignancies and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: GR1803 Injection in Patients With RRMM [Phase 2]
GR1803 is being studied in relapsed/refractory multiple myeloma in a Phase 2 trial, and recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation [Phase 2]
This is a Phase 2 clinical trial evaluating the combination of carfilzomib, lenalidomide, dexamethasone, and daratumumab in relapsed/refract…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]
This clinical trial update indicates that GR1803 is being evaluated in a Phase 2 study for relapsed/refractory multiple myeloma, with recrui…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
A completed real-world study by Regeneron evaluating clinical outcomes in patients with relapsed and refractory multiple myeloma.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Immuno-PRISM (PRecision Intervention Smoldering Myeloma) [Phase 2]
Phase 2 Immuno-PRISM trial evaluating a precision intervention for smoldering multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA) [Phase 2]
This Phase 2 trial compares elranatamab plus lenalidomide versus daratumumab plus lenalidomide as post-transplant maintenance in newly diagn…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma [NA]
This update describes a clinical study exploring patient-reported outcomes and wearable data in people with relapsed/refractory multiple mye…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma [Phase 2]
This Phase 2 clinical trial is evaluating daratumumab- and carfilzomib-based induction, consolidation, and maintenance therapy in transplant…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Ongoing University of Alberta-sponsored LONGEVITI study, LIVInG With chrONic Cancer TrEatments, is currently recruiting to evaluate cancer t…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma [NA]
This document outlines a clinical trial evaluating the safety, tolerability, radiation dose, distribution, PET imaging, and histological exp…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma [NA]
This clinical trial update describes a study evaluating a combination of Aponermin, pomalidomide, and dexamethasone in relapsed or refractor…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination [NA]
Clinical trial analyzing resistance and sensitivity mechanisms to teclistamab by single immune cell examination in multiple myeloma; current…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM [Phase 2]
A Phase 2 clinical trial update evaluating Isatuximab plus lenalidomide-dexamethasone (Rd) versus Rd in elderly patients (age 70 and older) …